| SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness CH Nguyen, T Glüxam, A Schlerka, K Bauer, AM Grandits, H Hackl, ... Scientific reports 9 (1), 9139, 2019 | 46 | 2019 |
| CGRP signaling via CALCRL increases chemotherapy resistance and stem cell properties in acute myeloid leukemia T Gluexam, AM Grandits, A Schlerka, CH Nguyen, J Etzler, T Finkes, ... International Journal of Molecular Sciences 20 (23), 5826, 2019 | 29 | 2019 |
| A novel interaction between complement inhibitor C4b-binding protein and plasminogen that enhances plasminogen activation V Agarwal, S Talens, AM Grandits, AM Blom Journal of Biological Chemistry 290 (30), 18333-18342, 2015 | 28 | 2015 |
| IL2RA Promotes Aggressiveness and Stem Cell–Related Properties of Acute Myeloid Leukemia CH Nguyen, A Schlerka, AM Grandits, E Koller, E van der Kouwe, ... Cancer research 80 (20), 4527-4539, 2020 | 25 | 2020 |
| All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells CH Nguyen, AM Grandits, LE Purton, H Sill, R Wieser Cell Cycle 19 (20), 2573-2588, 2020 | 21 | 2020 |
| Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A AM Grandits, R Wieser Experimental hematology 99, 1-11, 2021 | 16 | 2021 |
| Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness AM Grandits, CH Nguyen, A Schlerka, H Hackl, H Sill, J Etzler, E Heyes, ... Leukemia 35 (10), 2827-2839, 2021 | 12 | 2021 |
| CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1 C Pfeiffer, AM Grandits, H Asnagli, A Schneller, J Huber, N Zojer, ... Leukemia 38 (1), 181-192, 2024 | 9 | 2024 |
| New perspectives on biology, disease progression, and therapy response of head and neck cancer gained from single cell RNA sequencing and spatial transcriptomics G Heller, T Fuereder, AM Grandits, R Wieser Oncology Research 32 (1), 1, 2023 | 5 | 2023 |
| EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells AM Grandits, S Bromberger, G Heller, BA Reinoehl, E Tomasich, ... International Journal of Molecular Sciences 23 (3), 1050, 2022 | 5 | 2022 |
| Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells CH Nguyen, AM Grandits, GS Vassiliou, PB Staber, G Heller, R Wieser Biomedicines 8 (10), 385, 2020 | 5 | 2020 |
| SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapy AM Grandits, BA Reinoehl, R Wagner, P Kuess, F Eckert, AS Berghoff, ... Molecular Oncology, 0 | | |
Chi Huu Nguyen, PhDX4 PharmaceuticalsEmail yang diverifikasi di meduniwien.ac.at
